Industry News
-
Opus Genetics Enters Private Placement to Fund Inherited Retinal Disease AAV Gene Therapy Programs
Feb 13 2026 -
MD Anderson Cancer Center reports early signals for rapid autologous macrophage therapy RB-1355 in refractory lymphoma
Feb 13 2026 -
AI-guided CART platform targets two relapse drivers: poor persistence and antigen escape
Feb 13 2026 -
AAV Gene Therapy for Neovascular AMD: New Review Highlights Progress—and Persistent Barriers
Feb 13 2026 -
Genflow Reports Preliminary Survival and Functional Gains in Aged Dogs Treated with AAV8-SIRT6 Gene Therapy
Feb 13 2026 -
Apertura Launches “Open Aperture” Program to Expand Academic Access to TfR1 CapX, a BBB-Crossing AAV Capsid
Feb 13 2026 -
New Study Advances CRISPR-Based Gene Therapy for Inherited Skin Disease
Feb 13 2026 -
Vertex and CRISPR Project Nearly 3× Growth for Casgevy in 2026 as Patient Access Expands
Feb 13 2026 -
UMass Chan Licenses AAV9 Gene Therapy for UBA5 Disorder to Raiden Science Foundation
Feb 12 2026